EpiMonitor

Next-Gen Epilepsy Monitoring

Available in the US, UK, EU, AU, NZ and CA

Embrace2

Embrace2

Peace of Mind

No longer available for purchase

Empatica Logo
  • Solutions

    Empatica Health Monitoring Platform

    Empatica Health Monitoring Platform

    One platform, multiple applications

    Components

    EmbracePlus wearable
    EmbraceMini wearable
    New
    Care software suite
    eCOA
    Digital biomarkers
    Cloud API for Clinical Trials

    Use Cases

    Clinical Trials
    Designed for the patient, enhanced for the scientist
    Actigraphy
    The new standard to measure sleep and physical activity
    Contract Research Organizations
    Enhanced value and effortless integrations for CROs
    Parkinson's Monitoring
    New
    Improve patient outcomes with validated PKG measures
    Parkinson’s & Movement Disorders
    Digital endpoints for Parkinson's and movement disorders trials
    Academic Research
    Unlock the future of real-world research
    Go to store
  • Scientific Evidence

    Publications
    Scientific publications using our technology
    Case Studies
    Client success stories
  • Resources

    Compliance
    Global regulatory requirements
    Blog
    Thoughts and news
    Digital resources library
    Online and downloadable resources
    Support center
    Get support with our products
  • Company

    About us
    People with purpose
    Careers
    Join the mission
    Contact us
    Talk to our team
Contact Us
Empatica Logo
Empatica Health Monitoring Platform

Empatica Health Monitoring Platform

One platform, multiple applications

Components

EmbracePlus wearable
EmbraceMini wearable
New
Care software suite
eCOA
Digital biomarkers
Cloud API for Clinical Trials

Use Cases

Clinical Trials
Designed for the patient, enhanced for the scientist
Actigraphy
The new standard to measure sleep and physical activity
Contract Research Organizations
Enhanced value and effortless integrations for CROs
Parkinson's Monitoring
New
Improve patient outcomes with validated PKG measures
Parkinson’s & Movement Disorders
Digital endpoints for Parkinson's and movement disorders trials
Academic Research
Unlock the future of real-world research
Go to store
Publications
Scientific publications using our technology
Case Studies
Client success stories
Compliance
Global regulatory requirements
Blog
Thoughts and news
Digital resources library
Online and downloadable resources
Support center
Get support with our products
About us
People with purpose
Careers
Join the mission
Contact us
Talk to our team
EpiMonitor

Next-Gen Epilepsy Monitoring

Available in the US, UK, EU, AU, NZ and CA

Embrace2
Embrace2

Peace of Mind

No longer available for purchase

Contact Us
Research

E4 Bytes: Developing a model to predict migraine attacks using biosignals

Empatica

Empatica

Dec 1, 2020• 3 min read

LinkedinFacebookX

Researchers at the University of Oulu describe how they used the E4 to develop a model that predicts migraine attacks using biosignals.

The migraine is a chronic, incapacitating neurovascular disorder, characterized by attacks of severe headache and autonomic nervous system dysfunction, concerning 15% of people in developed countries. It is one of the most understated and incapacitating diseases in the world and costing yearly 111 Billion Euros in Europe only. However, the driving force to start this study was Heli’s son who started to have migraine attacks since he was 2-year-old.

The focus was on early detection of the attacks by using human measured biosignals. Empatica E4 was selected to be used in the study as it is the most capable device in the market, containing more sensors than any other wrist-worn device, and it has been found reliable in the previous studies as well. By using it, the aim was to develop a model that assists individuals to take their medication on time and hence help to avoid the pain in migraine.

Our first article [1] concentrated on the data gathering experiences of 11 volunteers. They had reported having migraine attacks at least twice in a month, and asked to wear the E4 24/7 for approximately one month. In our second article [2], the gathered data were used to train machine learning models for the early detection of migraine attacks. It was decided to concentrate on analyzing sleep time data as it contains much less disturbances caused by movement than day time data. The idea of this approach was to tell the user when he/she wakes up in the morning if he/she is going to have a migraine attack that day and take medication if needed.

Altogether, 110 features were extracted from each night’s biosignals, and used to train machine learning models. The experiments showed that early symptoms for migraine are highly personal. In fact, the balanced recognition accuracies using user-independent models were below 50%. It was shown that using personal recognition models the accuracy for detecting attacks one night prior is over 84%. While the number of study subjects was small and there is a lot of variation in the detection rates between the study subjects, this shows the potential of the introduced approach and Empatica E4.

References:
[1] Koskimäki, H., Mönttinen, H., Siirtola, P., Huttunen, H. L., Halonen, R., & Röning, J. (2017). Early detection of migraine attacks based on wearable sensors: experiences of data collection using Empatica E4. In Proceedings of the 2017 ACM International Joint Conference on Pervasive and Ubiquitous Computing and Proceedings of the 2017 ACM International Symposium on Wearable Computers (pp. 506-511).
[2] Siirtola, P., Koskimäki, H., Mönttinen, H., & Röning, J. (2018). Using sleep time data from wearable sensors for early detection of migraine attacks. Sensors, 18(5), 1374.

Company
About us
Careers
Legal
Blog
Empatica Health Monitoring Platform
Clinical Trials
Academic Research
Actigraphy
Parkinson's Monitoring
Parkinson’s & Movement Disorders
Log in
Care Portal
Care Lab Portal
Research Portal
Epilepsy Monitoring
EpiMonitor
Embrace2
Get Support
Contact Us
Manuals
Empatica
FacebookInstagramYouTubeTwitterLinkedin

Empatica Inc., 1 Broadway, 14th floor, Cambridge MA 02142 United States - Empatica Srl, Via Stendhal 36, 20144 Milano (MI), Italy

P. IVA IT07462810966. Copyright © 2026 Empatica Inc. - ISO 13485 Cert. No. 39050072201 - All rights reserved - Legal